Comparison Overview

Hetero Drugs Ltd

VS

Glenmark Pharmaceuticals

Hetero Drugs Ltd

India Hyderabad, 500018, IN
Last Update: 2025-12-09
View Profile
Between 750 and 799
www.heteroworld.com

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 10,001
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Glenmark Pharmaceuticals

Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099
Last Update: 2025-12-09
Between 750 and 799
http://www.glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 14,411
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/hetero-drugs-ltd.jpeg
Hetero Drugs Ltd
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/glenmark-pharmaceuticals.jpeg
Glenmark Pharmaceuticals
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Hetero Drugs Ltd
100%
Compliance Rate
0/4 Standards Verified
Glenmark Pharmaceuticals
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Hetero Drugs Ltd in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Glenmark Pharmaceuticals in 2025.

Incident History — Hetero Drugs Ltd (X = Date, Y = Severity)

Hetero Drugs Ltd cyber incidents detection timeline including parent company and subsidiaries

Incident History — Glenmark Pharmaceuticals (X = Date, Y = Severity)

Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/hetero-drugs-ltd.jpeg
Hetero Drugs Ltd
Incidents

No Incident

https://images.rankiteo.com/companyimages/glenmark-pharmaceuticals.jpeg
Glenmark Pharmaceuticals
Incidents

No Incident

FAQ

Glenmark Pharmaceuticals company demonstrates a stronger AI Cybersecurity Score compared to Hetero Drugs Ltd company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Glenmark Pharmaceuticals company has disclosed a higher number of cyber incidents compared to Hetero Drugs Ltd company.

In the current year, Glenmark Pharmaceuticals company and Hetero Drugs Ltd company have not reported any cyber incidents.

Neither Glenmark Pharmaceuticals company nor Hetero Drugs Ltd company has reported experiencing a ransomware attack publicly.

Neither Glenmark Pharmaceuticals company nor Hetero Drugs Ltd company has reported experiencing a data breach publicly.

Neither Glenmark Pharmaceuticals company nor Hetero Drugs Ltd company has reported experiencing targeted cyberattacks publicly.

Neither Hetero Drugs Ltd company nor Glenmark Pharmaceuticals company has reported experiencing or disclosing vulnerabilities publicly.

Neither Hetero Drugs Ltd nor Glenmark Pharmaceuticals holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Hetero Drugs Ltd company nor Glenmark Pharmaceuticals company has publicly disclosed detailed information about the number of their subsidiaries.

Glenmark Pharmaceuticals company employs more people globally than Hetero Drugs Ltd company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Hetero Drugs Ltd nor Glenmark Pharmaceuticals holds SOC 2 Type 1 certification.

Neither Hetero Drugs Ltd nor Glenmark Pharmaceuticals holds SOC 2 Type 2 certification.

Neither Hetero Drugs Ltd nor Glenmark Pharmaceuticals holds ISO 27001 certification.

Neither Hetero Drugs Ltd nor Glenmark Pharmaceuticals holds PCI DSS certification.

Neither Hetero Drugs Ltd nor Glenmark Pharmaceuticals holds HIPAA certification.

Neither Hetero Drugs Ltd nor Glenmark Pharmaceuticals holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

PCSX2 is a free and open-source PlayStation 2 (PS2) emulator. In versions 2.5.377 and below, an unchecked offset and size used in a memcpy operation inside PCSX2's CDVD SCMD 0x91 and SCMD 0x8F handlers allow a specially crafted disc image or ELF to cause an out-of-bounds read from emulator memory. Because the offset and size is controlled through MG header fields, a specially crafted ELF can read data beyond the bounds of mg_buffer and have it reflected back into emulated memory. This issue is fixed in version 2.5.378.

Published
Date
2025-12-12
Updated
Date
2025-12-12
Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Aircompressor is a library with ports of the Snappy, LZO, LZ4, and Zstandard compression algorithms to Java. In versions 3.3 and below, incorrect handling of malformed data in Java-based decompressor implementations for Snappy and LZ4 allow remote attackers to read previous buffer contents via crafted compressed input. With certain crafted compressed inputs, elements from the output buffer can end up in the uncompressed output, potentially leaking sensitive data. This is relevant for applications that reuse the same output buffer to uncompress multiple inputs. This can be the case of a web server that allocates a fix-sized buffer for performance purposes. There is similar vulnerability in GHSA-cmp6-m4wj-q63q. This issue is fixed in version 3.4.

Published
Date
2025-12-12
Updated
Date
2025-12-12
Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A vulnerability was found in itsourcecode COVID Tracking System 1.0. Affected by this vulnerability is an unknown functionality of the file /admin/?page=zone. The manipulation of the argument ID results in sql injection. The attack may be launched remotely. The exploit has been made public and could be used.

Published
Date
2025-12-12
Updated
Date
2025-12-12
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A vulnerability has been found in itsourcecode COVID Tracking System 1.0. Affected is an unknown function of the file /admin/login.php of the component Admin Login. The manipulation of the argument Username leads to sql injection. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used.

Published
Date
2025-12-12
Updated
Date
2025-12-12
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A flaw has been found in campcodes Online Student Enrollment System 1.0. This impacts an unknown function of the file /admin/register.php. Executing manipulation of the argument photo can lead to unrestricted upload. The attack can be launched remotely. The exploit has been published and may be used.

Published
Date
2025-12-12
Updated
Date
2025-12-12
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References